Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:2783-2789
Published online before print November 17, 2003, doi: 10.1161/01.CIR.0000103667.27493.32
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/22/2783    most recent
01.CIR.0000103667.27493.32v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romundstad, S.
Right arrow Articles by Ellekjær, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romundstad, S.
Right arrow Articles by Ellekjær, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Epidemiology
Right arrow Risk Factors

(Circulation. 2003;108:2783.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Microalbuminuria and All-Cause Mortality in Treated Hypertensive Individuals

Does Sex Matter?: The Nord-Trøndelag Health Study (HUNT), Norway

Solfrid Romundstad, MD; Jostein Holmen, PhD; Hans Hallan, MD; Kurt Kvenild, MD; Hanne Ellekjær, PhD

From the HUNT Research Center, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Verdal (S.R., J.H., K.K.); the Department of Internal Medicine, Levanger Hospital, Levanger (S.R., H.H., H.E.); and the Nærøy Health Center, Nærøy (K.K.), Norway.

Correspondence to Solfrid Romundstad, HUNT Research Center, Faculty of Medicine, NTNU, Neptunvegen 1, N-7650 Verdal, Norway. E-mail solfrid.romundstad{at}medisin.ntnu.no

Received March 19, 2003; de novo received June 17, 2003; revision received September 11, 2003; accepted September 12, 2003.

Background— In hypertensive individuals, few prospective studies are available in which the association between microalbuminuria (MA) and all-cause mortality in the 2 sexes have been studied within the same population.

Methods and Results— We conducted a 4.3-year follow-up of 2307 men and 3062 women (>=20 years old) with self-reported treated hypertension, all identified in the Nord-Trøndelag Health Study (HUNT), Norway, 1995 to 1997 (n=65 258). The main outcome measures were relative risk (RR) of all-cause mortality according to increasing albuminuria, defined at different levels of albumin-to-creatinine ratio (ACR). There was a consistent positive association between increasing ACR and all-cause mortality in men. The adjusted RR for ACR in the fourth quartile (>=1.70 mg/mmol) was 1.6 (95% CI, 1.0 to 2.6), compared with ACR in the first quartile (<0.55 mg/mmol). The corresponding RR in women was 1.5 (95% CI, 0.8 to 3.1). We found a positive association between mortality and increasing number of urine samples with ACR above different cutoff levels, especially in men. In 3 urine samples, the lowest ACR level associated with mortality in men was 0.86 mg/mmol, RR 1.6 (95% CI, 1.1 to 2.4). The sex differences persisted after exclusion of those who died during the first year of follow-up, those with hypertension not treated optimally, and those with known cardiovascular disease.

Conclusions— The association between ACR and all-cause mortality was stronger in treated hypertensive men than in women. The persistent sex differences indicate that hypertensive women tolerate MA better than men and that MA in women should be interpreted differently than in men.


Key Words: albuminuria • hypertension • mortality • follow-up studies • sex




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Baekken, I. Os, L. Sandvik, and O. Oektedalen
Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population
Nephrol. Dial. Transplant., May 9, 2008; (2008) gfn236v1.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Basi, P. Fesler, A. Mimran, and J. B. Lewis
Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?
Diabetes Care, February 1, 2008; 31(Supplement_2): S194 - S201.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Redon, F. Morales-Olivas, A. Galgo, M. A. Brito, J. Mediavilla, R. Marin, P. Rodriguez, S. Tranche, J. V. Lozano, C. Filozof, et al.
Urinary Albumin Excretion and Glomerular Filtration Rate across the Spectrum of Glucose Abnormalities in Essential Hypertension
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S236 - S245.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. P. Klausen, H. Scharling, G. Jensen, and J. S. Jensen
New Definition of Microalbuminuria in Hypertensive Subjects: Association With Incident Coronary Heart Disease and Death
Hypertension, July 1, 2005; 46(1): 33 - 37.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Klausen, K. Borch-Johnsen, B. Feldt-Rasmussen, G. Jensen, P. Clausen, H. Scharling, M. Appleyard, and J. S. Jensen
Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes
Circulation, July 6, 2004; 110(1): 32 - 35.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. SoRelle
Cardiovascular News
Circulation, December 2, 2003; 108 (22): e9072 - e9076.
[Full Text]